– Investigational therapeutic SER-109 has the potential to become the first-ever FDA-approved oral microbiome therapeutic –
– Anticipated product launch in the first half of 2023 –
https://finance.yahoo.com/news/seres-therapeutics-announces-completion-rolling-110000716.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.